Home > > > Report Detail

Global Human Chorionic Gonadotropin (HCG) Market Research Report 2023

Publisher Name :
Date: 27-Jan-2023
No. of pages: 91
Inquire Before Buying

Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology.

Highlights

The global Human Chorionic Gonadotropin (HCG) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

The major factors that fuel the growth of the market are the rising incidence of infertility issues among men and women, along with the increasing maternity age among women. In addition, the rising preference for hormonal drug therapy supplements the market growth.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Chorionic Gonadotropin (HCG), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Chorionic Gonadotropin (HCG).

The Human Chorionic Gonadotropin (HCG) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Human Chorionic Gonadotropin (HCG) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Chorionic Gonadotropin (HCG) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- EMD Serono, Inc

- Ferring B.V

- Merck & Co., Inc

- Bristol Myers Squibb Company

- Fresenius Kabi AG, LLC

- Scrippslabs

- Leebio

- Kamiya Biomedical Company

- Sanzyme

- Cigna

Segment by Type

- Natural Source Extraction

- Recombinant DNA Technology

Segment by Application

- Female Infertility Treatment

- Oligospermic Treatment

- Cryptorchidism Treatment

- Others

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Human Chorionic Gonadotropin (HCG) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Human Chorionic Gonadotropin (HCG) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Human Chorionic Gonadotropin (HCG) Market Research Report 2023

Table of Contents
1 Human Chorionic Gonadotropin (HCG) Market Overview
1.1 Product Overview and Scope of Human Chorionic Gonadotropin (HCG)
1.2 Human Chorionic Gonadotropin (HCG) Segment by Type
1.2.1 Global Human Chorionic Gonadotropin (HCG) Market Value Comparison by Type (2023-2029)
1.2.2 Natural Source Extraction
1.2.3 Recombinant DNA Technology
1.3 Human Chorionic Gonadotropin (HCG) Segment by Application
1.3.1 Global Human Chorionic Gonadotropin (HCG) Market Value by Application: (2023-2029)
1.3.2 Female Infertility Treatment
1.3.3 Oligospermic Treatment
1.3.4 Cryptorchidism Treatment
1.3.5 Others
1.4 Global Human Chorionic Gonadotropin (HCG) Market Size Estimates and Forecasts
1.4.1 Global Human Chorionic Gonadotropin (HCG) Revenue 2018-2029
1.4.2 Global Human Chorionic Gonadotropin (HCG) Sales 2018-2029
1.4.3 Global Human Chorionic Gonadotropin (HCG) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Human Chorionic Gonadotropin (HCG) Market Competition by Manufacturers
2.1 Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Human Chorionic Gonadotropin (HCG) Average Price by Manufacturers (2018-2023)
2.4 Global Human Chorionic Gonadotropin (HCG) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Human Chorionic Gonadotropin (HCG), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Chorionic Gonadotropin (HCG), Product Type & Application
2.7 Human Chorionic Gonadotropin (HCG) Market Competitive Situation and Trends
2.7.1 Human Chorionic Gonadotropin (HCG) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Chorionic Gonadotropin (HCG) Players Market Share by Revenue
2.7.3 Global Human Chorionic Gonadotropin (HCG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Chorionic Gonadotropin (HCG) Retrospective Market Scenario by Region
3.1 Global Human Chorionic Gonadotropin (HCG) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Human Chorionic Gonadotropin (HCG) Global Human Chorionic Gonadotropin (HCG) Sales by Region: 2018-2029
3.2.1 Global Human Chorionic Gonadotropin (HCG) Sales by Region: 2018-2023
3.2.2 Global Human Chorionic Gonadotropin (HCG) Sales by Region: 2024-2029
3.3 Global Human Chorionic Gonadotropin (HCG) Global Human Chorionic Gonadotropin (HCG) Revenue by Region: 2018-2029
3.3.1 Global Human Chorionic Gonadotropin (HCG) Revenue by Region: 2018-2023
3.3.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Region: 2024-2029
3.4 North America Human Chorionic Gonadotropin (HCG) Market Facts & Figures by Country
3.4.1 North America Human Chorionic Gonadotropin (HCG) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Human Chorionic Gonadotropin (HCG) Sales by Country (2018-2029)
3.4.3 North America Human Chorionic Gonadotropin (HCG) Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Chorionic Gonadotropin (HCG) Market Facts & Figures by Country
3.5.1 Europe Human Chorionic Gonadotropin (HCG) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Human Chorionic Gonadotropin (HCG) Sales by Country (2018-2029)
3.5.3 Europe Human Chorionic Gonadotropin (HCG) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Chorionic Gonadotropin (HCG) Market Facts & Figures by Country
3.6.1 Asia Pacific Human Chorionic Gonadotropin (HCG) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Country (2018-2029)
3.6.3 Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Chorionic Gonadotropin (HCG) Market Facts & Figures by Country
3.7.1 Latin America Human Chorionic Gonadotropin (HCG) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Human Chorionic Gonadotropin (HCG) Sales by Country (2018-2029)
3.7.3 Latin America Human Chorionic Gonadotropin (HCG) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Chorionic Gonadotropin (HCG) Sales by Type (2018-2029)
4.1.1 Global Human Chorionic Gonadotropin (HCG) Sales by Type (2018-2023)
4.1.2 Global Human Chorionic Gonadotropin (HCG) Sales by Type (2024-2029)
4.1.3 Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2018-2029)
4.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Type (2018-2029)
4.2.1 Global Human Chorionic Gonadotropin (HCG) Revenue by Type (2018-2023)
4.2.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Type (2024-2029)
4.2.3 Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2018-2029)
4.3 Global Human Chorionic Gonadotropin (HCG) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Human Chorionic Gonadotropin (HCG) Sales by Application (2018-2029)
5.1.1 Global Human Chorionic Gonadotropin (HCG) Sales by Application (2018-2023)
5.1.2 Global Human Chorionic Gonadotropin (HCG) Sales by Application (2024-2029)
5.1.3 Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2018-2029)
5.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Application (2018-2029)
5.2.1 Global Human Chorionic Gonadotropin (HCG) Revenue by Application (2018-2023)
5.2.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Application (2024-2029)
5.2.3 Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2018-2029)
5.3 Global Human Chorionic Gonadotropin (HCG) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 EMD Serono, Inc
6.1.1 EMD Serono, Inc Corporation Information
6.1.2 EMD Serono, Inc Description and Business Overview
6.1.3 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product Portfolio
6.1.5 EMD Serono, Inc Recent Developments/Updates
6.2 Ferring B.V
6.2.1 Ferring B.V Corporation Information
6.2.2 Ferring B.V Description and Business Overview
6.2.3 Ferring B.V Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Ferring B.V Human Chorionic Gonadotropin (HCG) Product Portfolio
6.2.5 Ferring B.V Recent Developments/Updates
6.3 Merck & Co., Inc
6.3.1 Merck & Co., Inc Corporation Information
6.3.2 Merck & Co., Inc Description and Business Overview
6.3.3 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Product Portfolio
6.3.5 Merck & Co., Inc Recent Developments/Updates
6.4 Bristol Myers Squibb Company
6.4.1 Bristol Myers Squibb Company Corporation Information
6.4.2 Bristol Myers Squibb Company Description and Business Overview
6.4.3 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product Portfolio
6.4.5 Bristol Myers Squibb Company Recent Developments/Updates
6.5 Fresenius Kabi AG, LLC
6.5.1 Fresenius Kabi AG, LLC Corporation Information
6.5.2 Fresenius Kabi AG, LLC Description and Business Overview
6.5.3 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Product Portfolio
6.5.5 Fresenius Kabi AG, LLC Recent Developments/Updates
6.6 Scrippslabs
6.6.1 Scrippslabs Corporation Information
6.6.2 Scrippslabs Description and Business Overview
6.6.3 Scrippslabs Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Scrippslabs Human Chorionic Gonadotropin (HCG) Product Portfolio
6.6.5 Scrippslabs Recent Developments/Updates
6.7 Leebio
6.6.1 Leebio Corporation Information
6.6.2 Leebio Description and Business Overview
6.6.3 Leebio Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Leebio Human Chorionic Gonadotropin (HCG) Product Portfolio
6.7.5 Leebio Recent Developments/Updates
6.8 Kamiya Biomedical Company
6.8.1 Kamiya Biomedical Company Corporation Information
6.8.2 Kamiya Biomedical Company Description and Business Overview
6.8.3 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product Portfolio
6.8.5 Kamiya Biomedical Company Recent Developments/Updates
6.9 Sanzyme
6.9.1 Sanzyme Corporation Information
6.9.2 Sanzyme Description and Business Overview
6.9.3 Sanzyme Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sanzyme Human Chorionic Gonadotropin (HCG) Product Portfolio
6.9.5 Sanzyme Recent Developments/Updates
6.10 Cigna
6.10.1 Cigna Corporation Information
6.10.2 Cigna Description and Business Overview
6.10.3 Cigna Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Cigna Human Chorionic Gonadotropin (HCG) Product Portfolio
6.10.5 Cigna Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Chorionic Gonadotropin (HCG) Industry Chain Analysis
7.2 Human Chorionic Gonadotropin (HCG) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Chorionic Gonadotropin (HCG) Production Mode & Process
7.4 Human Chorionic Gonadotropin (HCG) Sales and Marketing
7.4.1 Human Chorionic Gonadotropin (HCG) Sales Channels
7.4.2 Human Chorionic Gonadotropin (HCG) Distributors
7.5 Human Chorionic Gonadotropin (HCG) Customers
8 Human Chorionic Gonadotropin (HCG) Market Dynamics
8.1 Human Chorionic Gonadotropin (HCG) Industry Trends
8.2 Human Chorionic Gonadotropin (HCG) Market Drivers
8.3 Human Chorionic Gonadotropin (HCG) Market Challenges
8.4 Human Chorionic Gonadotropin (HCG) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Human Chorionic Gonadotropin (HCG) Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Human Chorionic Gonadotropin (HCG) Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Human Chorionic Gonadotropin (HCG) Market Competitive Situation by Manufacturers in 2022
Table 4. Global Human Chorionic Gonadotropin (HCG) Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Human Chorionic Gonadotropin (HCG) Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Human Chorionic Gonadotropin (HCG) Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Human Chorionic Gonadotropin (HCG), Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Human Chorionic Gonadotropin (HCG), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Chorionic Gonadotropin (HCG), Product Type & Application
Table 12. Global Key Manufacturers of Human Chorionic Gonadotropin (HCG), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Chorionic Gonadotropin (HCG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Chorionic Gonadotropin (HCG) as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Chorionic Gonadotropin (HCG) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Human Chorionic Gonadotropin (HCG) Sales by Region (2018-2023) & (K Units)
Table 18. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Region (2018-2023)
Table 19. Global Human Chorionic Gonadotropin (HCG) Sales by Region (2024-2029) & (K Units)
Table 20. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Region (2024-2029)
Table 21. Global Human Chorionic Gonadotropin (HCG) Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Region (2018-2023)
Table 23. Global Human Chorionic Gonadotropin (HCG) Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Region (2024-2029)
Table 25. North America Human Chorionic Gonadotropin (HCG) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Human Chorionic Gonadotropin (HCG) Sales by Country (2018-2023) & (K Units)
Table 27. North America Human Chorionic Gonadotropin (HCG) Sales by Country (2024-2029) & (K Units)
Table 28. North America Human Chorionic Gonadotropin (HCG) Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Human Chorionic Gonadotropin (HCG) Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Human Chorionic Gonadotropin (HCG) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Human Chorionic Gonadotropin (HCG) Sales by Country (2018-2023) & (K Units)
Table 32. Europe Human Chorionic Gonadotropin (HCG) Sales by Country (2024-2029) & (K Units)
Table 33. Europe Human Chorionic Gonadotropin (HCG) Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Human Chorionic Gonadotropin (HCG) Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Human Chorionic Gonadotropin (HCG) Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Human Chorionic Gonadotropin (HCG) Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Human Chorionic Gonadotropin (HCG) Sales (K Units) by Type (2018-2023)
Table 51. Global Human Chorionic Gonadotropin (HCG) Sales (K Units) by Type (2024-2029)
Table 52. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2018-2023)
Table 53. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2024-2029)
Table 54. Global Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2018-2023)
Table 57. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2024-2029)
Table 58. Global Human Chorionic Gonadotropin (HCG) Price (USD/Unit) by Type (2018-2023)
Table 59. Global Human Chorionic Gonadotropin (HCG) Price (USD/Unit) by Type (2024-2029)
Table 60. Global Human Chorionic Gonadotropin (HCG) Sales (K Units) by Application (2018-2023)
Table 61. Global Human Chorionic Gonadotropin (HCG) Sales (K Units) by Application (2024-2029)
Table 62. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2018-2023)
Table 63. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2024-2029)
Table 64. Global Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Human Chorionic Gonadotropin (HCG) Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2018-2023)
Table 67. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2024-2029)
Table 68. Global Human Chorionic Gonadotropin (HCG) Price (USD/Unit) by Application (2018-2023)
Table 69. Global Human Chorionic Gonadotropin (HCG) Price (USD/Unit) by Application (2024-2029)
Table 70. EMD Serono, Inc Corporation Information
Table 71. EMD Serono, Inc Description and Business Overview
Table 72. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product
Table 74. EMD Serono, Inc Recent Developments/Updates
Table 75. Ferring B.V Corporation Information
Table 76. Ferring B.V Description and Business Overview
Table 77. Ferring B.V Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Ferring B.V Human Chorionic Gonadotropin (HCG) Product
Table 79. Ferring B.V Recent Developments/Updates
Table 80. Merck & Co., Inc Corporation Information
Table 81. Merck & Co., Inc Description and Business Overview
Table 82. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Product
Table 84. Merck & Co., Inc Recent Developments/Updates
Table 85. Bristol Myers Squibb Company Corporation Information
Table 86. Bristol Myers Squibb Company Description and Business Overview
Table 87. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product
Table 89. Bristol Myers Squibb Company Recent Developments/Updates
Table 90. Fresenius Kabi AG, LLC Corporation Information
Table 91. Fresenius Kabi AG, LLC Description and Business Overview
Table 92. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Product
Table 94. Fresenius Kabi AG, LLC Recent Developments/Updates
Table 95. Scrippslabs Corporation Information
Table 96. Scrippslabs Description and Business Overview
Table 97. Scrippslabs Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Scrippslabs Human Chorionic Gonadotropin (HCG) Product
Table 99. Scrippslabs Recent Developments/Updates
Table 100. Leebio Corporation Information
Table 101. Leebio Description and Business Overview
Table 102. Leebio Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Leebio Human Chorionic Gonadotropin (HCG) Product
Table 104. Leebio Recent Developments/Updates
Table 105. Kamiya Biomedical Company Corporation Information
Table 106. Kamiya Biomedical Company Description and Business Overview
Table 107. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product
Table 109. Kamiya Biomedical Company Recent Developments/Updates
Table 110. Sanzyme Corporation Information
Table 111. Sanzyme Description and Business Overview
Table 112. Sanzyme Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Sanzyme Human Chorionic Gonadotropin (HCG) Product
Table 114. Sanzyme Recent Developments/Updates
Table 115. Cigna Corporation Information
Table 116. Cigna Description and Business Overview
Table 117. Cigna Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Cigna Human Chorionic Gonadotropin (HCG) Product
Table 119. Cigna Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Human Chorionic Gonadotropin (HCG) Distributors List
Table 123. Human Chorionic Gonadotropin (HCG) Customers List
Table 124. Human Chorionic Gonadotropin (HCG) Market Trends
Table 125. Human Chorionic Gonadotropin (HCG) Market Drivers
Table 126. Human Chorionic Gonadotropin (HCG) Market Challenges
Table 127. Human Chorionic Gonadotropin (HCG) Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Chorionic Gonadotropin (HCG)
Figure 2. Global Human Chorionic Gonadotropin (HCG) Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Human Chorionic Gonadotropin (HCG) Market Share by Type in 2022 & 2029
Figure 4. Natural Source Extraction Product Picture
Figure 5. Recombinant DNA Technology Product Picture
Figure 6. Global Human Chorionic Gonadotropin (HCG) Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Human Chorionic Gonadotropin (HCG) Market Share by Application in 2022 & 2029
Figure 8. Female Infertility Treatment
Figure 9. Oligospermic Treatment
Figure 10. Cryptorchidism Treatment
Figure 11. Others
Figure 12. Global Human Chorionic Gonadotropin (HCG) Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Human Chorionic Gonadotropin (HCG) Market Size (2018-2029) & (US$ Million)
Figure 14. Global Human Chorionic Gonadotropin (HCG) Sales (2018-2029) & (K Units)
Figure 15. Global Human Chorionic Gonadotropin (HCG) Average Price (USD/Unit) & (2018-2029)
Figure 16. Human Chorionic Gonadotropin (HCG) Report Years Considered
Figure 17. Human Chorionic Gonadotropin (HCG) Sales Share by Manufacturers in 2022
Figure 18. Global Human Chorionic Gonadotropin (HCG) Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Human Chorionic Gonadotropin (HCG) Players: Market Share by Revenue in 2022
Figure 20. Human Chorionic Gonadotropin (HCG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Human Chorionic Gonadotropin (HCG) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Human Chorionic Gonadotropin (HCG) Sales Market Share by Country (2018-2029)
Figure 23. North America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by Country (2018-2029)
Figure 27. Europe Human Chorionic Gonadotropin (HCG) Revenue Market Share by Country (2018-2029)
Figure 28. Germany Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue Market Share by Region (2018-2029)
Figure 35. China Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Taiwan Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Philippines Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Human Chorionic Gonadotropin (HCG) Sales Market Share by Country (2018-2029)
Figure 46. Latin America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Human Chorionic Gonadotropin (HCG) Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. U.A.E Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Human Chorionic Gonadotropin (HCG) by Type (2018-2029)
Figure 56. Global Revenue Market Share of Human Chorionic Gonadotropin (HCG) by Type (2018-2029)
Figure 57. Global Human Chorionic Gonadotropin (HCG) Price (USD/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Human Chorionic Gonadotropin (HCG) by Application (2018-2029)
Figure 59. Global Revenue Market Share of Human Chorionic Gonadotropin (HCG) by Application (2018-2029)
Figure 60. Global Human Chorionic Gonadotropin (HCG) Price (USD/Unit) by Application (2018-2029)
Figure 61. Human Chorionic Gonadotropin (HCG) Value Chain
Figure 62. Human Chorionic Gonadotropin (HCG) Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
  • Global Keyhole Limpet Hemocyanin (Klh) Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 23-Mar-2023        Price: US 3260 Onwards        Pages: 118
    The Keyhole Limpet Hemocyanin (Klh) market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Keyhole Limpet Hemocyanin (Klh) industry, and breaks down according to the type, application, and consumption area of Keyhole Limpet Hemocyanin (Klh). The report also introduces players in the industry from the perspective of the industry ch......
  • Global Recombinant Protein Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 23-Mar-2023        Price: US 3260 Onwards        Pages: 127
    The Recombinant Protein market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Recombinant Protein industry, and breaks down according to the type, application, and consumption area of Recombinant Protein. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describe......
  • Global Chitosan Gel Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 23-Mar-2023        Price: US 3260 Onwards        Pages: 108
    The Chitosan Gel market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Chitosan Gel industry, and breaks down according to the type, application, and consumption area of Chitosan Gel. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading compani......
  • Global Chlorhexidine Gluconate (CHG) Solution Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 21-Mar-2023        Price: US 3260 Onwards        Pages: 124
    Chlorhexidine gluconate is a biguanide chlorobenzene with a wide range of antimicrobial activity. It is the most Gram-positive (10mcg/ml) and Gram-negative (50mcg/ml) bacteria at pH 5.0-8.0. effective The Chlorhexidine Gluconate (CHG) Solution market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Chlorhexidine Gluconate (C......
  • Global Hemostat Powder Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 21-Mar-2023        Price: US 3260 Onwards        Pages: 110
    Hemostat powder , such as QuikClot and Celox, rapidly stop bleeding by either promoting coagulation or contracting tissue. Hemostatics can be critical to saving someone's life making them an excellent part of a first aid kit. The Hemostat Powder market revenue was 361.37 Million USD in 2022, and will reach 578.21 Million USD in 2028, with a CAGR of 8.15% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Hemostat Powde......
  • Global Herbal Medicine Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 21-Mar-2023        Price: US 3260 Onwards        Pages: 116
    The Herbal Medicine market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Herbal Medicine industry, and breaks down according to the type, application, and consumption area of Herbal Medicine. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leadin......
  • Global Medicinal Mushroom Extracts Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 21-Mar-2023        Price: US 3260 Onwards        Pages: 122
    The Medicinal Mushroom Extracts market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Medicinal Mushroom Extracts industry, and breaks down according to the type, application, and consumption area of Medicinal Mushroom Extracts. The report also introduces players in the industry from the perspective of the industry chain and mark......
  • Global Animal Antibacterial And Antibiotics Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 21-Mar-2023        Price: US 3260 Onwards        Pages: 110
    Animal Antibacterial and Antibiotics are usually used in animal feed, antibiotic use whether for therapy or prevention of bacterial diseases, or as performance enhancers will result in antibiotic resistant micro-organisms, not only among pathogens but also among bacteria of the endogenous microflora of animals. The extent to which antibiotic use in animals will contribute to the antibiotic resistance in humans is still under much debate. The Animal Antibacterial And Antibiotics market rev......
  • Global Analytical Standards Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 108
    The Analytical Standards market revenue was 2055.18 Million USD in 2022, and will reach 3275.31 Million USD in 2028, with a CAGR of 8.08% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Analytical Standards industry, and breaks down according to the type, application, and consumption area of Analytical Standards. The report also introduces players in the industry from the perspective of the industry chain and marketing cha......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs